Lucimycin, an antifungal peptide from the therapeutic maggot of the common green bottle fly Lucilia sericata

Biological Chemistry

Volumn 395, Issue 6, 2014, Pages 649-656

  Pöppel, Anne Kathrin ^a,b   Koch, Aline ^b   Kogel, Karl Heinz ^b   Vogel, Heiko ^c   Kollewe, Christian ^a   Wiesner, Jochen ^a   Vilcinskas, Andreas ^a,b  

^a FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c MAX PLANCK INSTITUTE FOR CHEMICAL ECOLOGY   (Germany)

Author keywords

antifungal peptides; crop protection; fungal pathogens; Lucilia sericata; lucimycin; wound healing maggots

Indexed keywords

AMINO ACID; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; COMPLEMENTARY DNA; LUCENSOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; PEPTIDE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASCOMYCETES; BASIDIOMYCETES; CLONING; CONTROLLED STUDY; DNA ISOLATION; HETEROLOGOUS EXPRESSION; INNATE IMMUNITY; LUCILIA SERICATA; MAGGOT; MOLECULAR WEIGHT; MUTANT; NONHUMAN; OOMYCETES; PHYTOPHTORA PARASITICA; PLANT DISEASE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; TRANSGENIC CROP; ZYGOMYCETES; ANIMAL; LARVA; METABOLISM; SEQUENCE ANALYSIS;

ANIMALS; ANTIFUNGAL AGENTS; LARVA; LUCENSOMYCIN; PEPTIDES; SEQUENCE ANALYSIS, PROTEIN;

EID: 84899867197     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0263     Document Type: Article

References (33)

1. Aerts, A.M., Francois, I.E., Cammue, B.P., and Thevissen, K. (2008). The mode of antifungal action of plant, insect and human defensins. Cell. Mol. Life. Sci. 65, 2069-2079.
2. Ali, G.S. and Reddy, A.S. (2000). Inhibition of fungal and bacterial plant pathogens by synthetic peptides: in vitro growth inhibition, interaction between peptides and inhibition of disease progression. Mol. Plant. Microbe. Interact. 13, 847-859.
3. Altincicek, B. and Vilcinskas, A. (2007). Analysis of the immuneinducible transcriptome from microbial stress resistant, rat-tailed maggots of the drone fly Eristalis tenax. BMC Genomics 8, 326.
4. Altincicek, B. and Vilcinskas, A. (2009). Septic injury-inducible genes in medicinal maggots of the green blow fly Lucilia sericata. Insect Mol. Biol. 18, 119-125.
5. Arvanitis, M., Glavis-Bloom, J., and Mylonakis, E. (2013). Invertebrate models of fungal infection. Biochim. Biophys. Acta. 1832, 1378-1383.
6. Bexfield, A., Nigam, Y., Thomas, S., and Ratcliffe, N.A. (2004). Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect. 6, 1297-1304.
7. Cerovsky, V., Zdarek, J., Fucik, V., Monincova, L., Voburka, Z., and Bem, R. (2010). Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericata. Cell. Mol. Life Sci. 67, 455-466.
8. Cerovsky, V., Slaninova, J., Fucik, V., Monincova, L., Bednarova, L., Malon, P., and Stokrova, J. (2011). Lucifensin, a novel insect defensin of medicinal maggots: synthesis and structural study. Chembiochem. 12, 1352-1361.
9. Chambers L., Woodrow, S., Brown, A.P., Harris, P.D., Phillips, D., Hall, M., Church, J.C., and Pritchard, D.I. (2003). Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br. J. Dermatol. 148 14-23.
10. Church, J.C. (1996). The traditional use of maggots in wound healing, and the development of larva therapy (biosurgery) in modern medicine. J. Altern. Complement. Med. 2, 525-527.
11. Desalermos, A., Fuchs, B.B., and Mylonakis, E. (2012). Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog. 8, e1002451.
12. Huberman, L., Gollop, N., Mumcuoglu, K.Y., Breuer, E., Bhusare, S.R., Shai, Y., and Galun, R. (2007). Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med. Vet. Entomol. 21, 127-131.
13. Koch, A., Khalifa, W., Langen, G., Vilcinskas, A., Kogel, K.-H., and Imani, J. (2012). The antimicrobial peptide thanatin reduces fungal infections in Arabidopsis. J. Phytopathol. 160, 606-610.
14. Kumar, R., Chadha, S., Saraswat, D., Bajwa, J.S., Li, R.A., Conti, H.R., and Edgerton, M. (2011). Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. J. Biol. Chem. 286, 43748-43758.
15. Langen, G., Imani, J., Altincicek, B., Kieseritzky, G., Kogel, K.H., and Vilcinskas, A. (2006). Transgenic expression of gallerimycin, a novel antifungal insect defensin from the greater wax moth Galleria mellonella, confers resistance to pathogenic fungi in tobacco. Biol. Chem. 387, 549-557.
16. Louis, B. and Roy, P. (2010). Engineered pathogenesis related and antimicrobial proteins weaponry against Phytopthora infestans in potato plant. Biotechnol. Mol. Biol. Rev. 5, 61-66.
17. Mukherjee, K., Hain, T., Fischer, R., Chakraborty, T., and Vilcinskas, A. (2013). Brain infection and activation of neuronal repair mechanisms by the human pathogen Listeria monocytogenes in the lepidopteran model host Galleria mellonella. Virulence 4, 324-332.
18. Mumcuoglu, K.Y., Ingber, A., Gilead, L., Stessman, J., Friedmann, R., Schulman, H., Bichucher, H., Ioffe-Uspensky, I., Miller, J., Galun, R., et al. (1999). Maggot therapy for the treatment of intractable wounds. Internat. J. Dermatol. 38, 623-627.
19. Nigam, Y., Bexfield, A., Thomas, S., and Ratcliffe, N.A. (2006a). Maggot therapy: the science and implication for cam part I-history and bacterial resistance. Evid. Based complement. Alternat. Med. 3, 223-227.
20. Nigam, Y., Bexfield, A., Thomas, S., and Ratcliffe, N.A. (2006b). Maggot therapy: the science and implication for cam part II-maggots combat infection. Evid. Based complement. Alternat. Med. 3, 303-308.
21. Rahnamaeian, M., Langen, G., Imani, J., Khalifa, W., Altincicek, B., von Wettstein, D., Kogel, K.H., and Vilcinskas, A. (2009). Insect peptide metchnikowin confers on barley a selective capacity for resistance to fungal ascomycetes pathogens. J. Exp. Bot. 60, 4105-4114.
22. Ratcliffe, N.A., Mello, C.B., Garcia, E.S., Butt, T.M., and Azambuja, P. (2011). Insect natural products and processes: new treatments for human disease. Insect Biochem. Mol. Biol. 41, 747-769.
23. Schuhmann, B., Seitz, V., Vilcinskas, A., and Podsiadlowski, L. (2003). Cloning and expression of gallerimycin, an antifungal peptide expressed in immune response of greater wax moth larvae, Galleria mellonella. Arch. Insect Biochem. Physiol. 53, 125-133.
24. Seitz, V., Clermont, A., Wedde, M., Hummel, M., Vilcinskas, A., Schlatterer, K., and Podsiadlowski, L. (2003). Identification of immunorelevant genes from greater wax moth (Galleria mellonella) by a subtractive hybridization approach. Dev. Comp. Immunol. 27, 207-215.
25. Thomas, S., Jones, M., Shutler, S., and Jones, S. (1996). Using larvae in modern wound management. J. Wound Care 5, 60-69.
26. Vilcinskas, A. (2010). Coevolution between pathogen-derived proteinases and proteinase inhibitors of host insects. Virulence 1, 206-214.
27. Vilcinskas, A. (2011a). Anti-infective therapeutics from the lepidopteran model host Galleria mellonella. Curr. Pharm. Des. 17, 1240-1245.
28. Vilcinskas, A. (2011b). From traditional maggot therapy to modern biosurgery. In: Insect Biotechnology, A. Vilcinskas, ed. (Dordrecht, Netherlands: Springer), pp. 67-75.
29. Vilcinskas, A. (2013). Evolutionary plasticity of insect immunity. J. Insect Physiol. 59, 123-129.
30. Vilcinskas, A. and Gross, J. (2005). Drugs from bugs: the use of insects as a valuable source of transgenes with potential in modern plant protection strategies. J. Pest Sci. 78, 187-191.
31. Vogel, H., Altincicek, B., Glockner, G., and Vilcinskas, A. (2011). A comprehensive transcriptome and immune-gene repertoire of the lepidopteran model host Galleria mellonella. BMC Genomics 12, 308.
32. Wang, Y., Li, D.D., Jiang, Y.Y., and Mylonakis, E. (2013). Utility of insects for studying human pathogens and evaluating new antimicrobial agents. Adv. Biochem. Eng. Biotechnol. 135, 1-25.
33. Wiesner, J. and Vilcinskas, A. (2010). Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1, 440-464.